阿司匹林对体外培养骨髓基质细胞成骨性分化的影响

目的:探讨阿司匹林对骨髓基质细胞成骨性分化的影响。方法:培养SD大鼠骨髓基质细胞(BMSCs),传代3次后进行成骨诱导分化,诱导培养基中加入不同浓度阿司匹林(0.5、1、2、5、10mmol/L),同时设立对照组。采用cck-8法分析细胞增殖情况。比较阿司匹林组与对照组在细胞碱性磷酸酶(ALP)活性、骨钙素(OC)分泌量、钙结节染色等方面的成骨性差异。结果:阿司匹林无促进细胞增殖活性,而高浓度阿司匹林能够强烈抑制细胞增殖。0.5、1、2mmol/L浓度阿司匹林可促进BMSCs的成骨性分化,中低浓度组碱性磷酸酶含量、骨钙素分泌量在不同阶段显著高于对照组。14天茜素红染色可见中低浓度组钙结节数量高于对照组。结论:中低浓度阿司匹林作用于骨髓基质细胞可促进其成骨细胞特性表达,这表明阿司匹林有促进骨代谢合成的作用。     

不同干预时间正弦电磁场对大鼠骨髓基质干细胞成骨性分化的影响

目的:研究不同治疗时间正弦电磁场(50 Hz,1.8mT)对体外培养大鼠骨髓间充质干细胞成骨性分化的影响,筛选出最佳临床治疗时间.方法:采用贴壁筛选法培养原代大鼠骨髓间充质干细胞,每天在频率为50 Hz,强度为1.8 mT的磁场环境中处理0.5 h、1.0h、1.5 h、2.0h和2.5h;同时设立未经电磁场处理的细胞作为对照组.于处理后的第3 d、6d、9d和12 d分别测定细胞碱性磷酸酶活性、骨钙素分泌量、钙化结节数以及Ⅰ型胶原表达量,并比较各组间差异;于处理后12 h提取细胞总RNA,用RT Real-Time PCR法检测成骨性分化基因Osterix表达情况.结果:正弦电磁场干预1.0h能明显促进骨髓间充质干细胞的成骨性分化,表现在该组的碱性磷酸酶活性、骨钙素分泌量、钙化结节数、Ⅰ型胶原表达量以及成骨性分化基因的表达量最高,亦显著高于对照组(P＜0.05).结论:50Hz、1.8mT强度的正弦电磁场能促进骨髓间充质干细胞的成骨性分化,以作用1.0h成骨效果最为明显.     

罗非鱼鱼皮酶解液对体外培养大鼠骨髓基质细胞的影响

目的:观察两种罗非鱼鱼皮酶解液对大鼠骨髓基质细胞的影响。方法:用密度梯度离心和贴壁筛选的方法获得骨髓基质细胞,用碱性磷酸酶染色法观察是否成功诱导骨髓基质细胞向成骨细胞分化,并分别采用MTT法和PNPP法测定两种酶解液对骨髓基质细胞增殖和碱性磷酸酶活性的影响。结果:密度梯度离心和贴壁筛选可得到较为均一的骨髓基质细胞。这些骨髓基质细胞诱导后可以向成骨细胞分化。两种酶解液作用于骨髓基质细胞时,在浓度0.1mg·ml~(-1)均可以促进骨髓基质细胞增殖,在浓度0.1mg·ml~(-1)1,0.01mg·ml~(-1)均可以提高骨髓基质细胞碱性磷酸酶活力。实验用两种酶解液的三个浓度与成骨诱导液协同作用于骨髓基质细胞时,均没有促进细胞增殖和提高碱性磷酸酶活性的显著作用。结论:两种酶解液可以促进骨髓基质细胞增殖,提高细胞碱性磷酸酶活力;与成骨诱导液协同作用于骨髓基质细胞时,对细胞增殖和碱性磷酸酶活性没有显著促进及提高作用。     

降钙素相关肽诱导SD大鼠骨髓间充质干细胞成骨分化的机制

目的:研究外源性降钙素基因相关肽(calcitonin gene-relate peptide,CGRP)对SD大鼠骨髓来源间充质干细胞(BMSCs)增殖和成骨分化功能的影响。方法:采用贴壁法分离骨髓间充质干细胞,扩增传代至第三代,根据分组,培养体系中添加含不同浓度(10-11～10-6mol/L)CGRP的条件培养液,WST-1法检测细胞增殖能力;碱性磷酸酶染色及钙结节染色法观察CGRP诱导BMSCs向成骨细胞分化、矿化的效果。采用RT-PCR方法检测碱性磷酸酶(ALP)、I型胶原(COLL-I)、BMP-2、RunX2、骨粘连蛋白(Osteonectin,ON)等成骨相关细胞因子mRNA的表达。结果:增殖率测定CGRP组各浓度均较对照组增加,且呈剂量依赖关系,CGRP浓度大于1×10-10mol/L时差异有显著性(P<0.05);碱磷酶染色与钙结节染色结果显示,CGRP组均有阳性显色,对照组无显色或显色不明显。CGRP组的细胞因子表达较对照组显著升高(P<0.05)。结论:适当浓度的CGRP能够直接促进体外培养的BMSCs增殖,并可短期内诱导其在向成骨细胞分化。CGRP可能在骨修复及骨重建中发挥重要的作用...     

在海藻酸钠凝胶上诱导骨髓间充质干细胞分化为成骨细胞

通过在海藻酸钠凝胶上诱导bMSCs向成骨细胞分化,探讨其对骨髓间充质干细胞（bone mesenchymal stem cells, bMSCs）的生物学效应。采用MTT、甲苯胺蓝染色、von Kossa染色和RT-PCR分别检测细胞的增殖、生长形态、诱导后细胞的钙化结节和成骨相关基因的表达。实验组bMSCs生长状况良好、细胞增殖迅速,与对照组的增殖无差异;bMSCs成集落样生长明显,集落中央细胞重叠生长形成钙化结节;培养至12d,实验组和对照组的成骨相关基因,包括碱性磷酸酶、I型胶原和骨钙素,均为阳性表达,但实验组的表达量高于对照组。海藻酸钠凝胶能够促进bMSCs向成骨细胞的分化,是良好的骨组织工程支架材料。     

纺壳聚糖聚己内酯纳米纤维膜对鼠骨髓间充质干细胞成牙功能影响

摘要 目的：探讨纺壳聚糖聚己内酯纳米纤维膜对鼠骨髓间充质干细胞（bone marrow mesenchymal stem cell,BMSC）成牙功能影响。方法：从SD大鼠分离BMSCs,然后随机分为两组,一组与纺壳聚糖聚己内酯纳米纤维膜进行共培养（共培养组）;另一组不进行共培养,直接在细胞板内培养（对照组）。检测细胞增殖指数、细胞钙含量、碱性磷酸酶活性与成骨相关基因表达水平。结果：BMSCs细胞形态较为单一,呈纤维样、旋涡状梭形、生长,长期培养可见细胞成片生长并相互融合。与共培养24 h相比,共培养48 h后共培养组细胞增殖指数、钙含量、碱性磷酸酶活性以及O成骨相关基因CN、Col1、Runx2等相对表达水平均显著增加（P<0.05）。共培养24 h与48 h后,共培养组的细胞增殖指数、钙含量、碱性磷酸酶活性和骨钙素（OCN）、Ⅰ型胶原α1（Col1）、Runt相关转录因子2（Runx2）等成骨相关基因相对表达水平都显著高于对照组（P<0.05）。结论：纺壳聚糖聚己内酯纳米纤维膜在BMSCs中的应用能促进细胞增殖,提高碱性磷酸酶活性与钙含量,促进成骨相关基因的表达,从而发挥成牙功能。     

高糖和bFGF对骨髓间充质干细胞成骨分化的影响

目的：骨组织的形成是一个复杂的过程,受多种因素的影响,糖尿病所导致的持续高血糖对于成骨分化的影响机制尚不明确,以及在此分化过程中的各种细胞因子的作用机理仍不明了,现拟通过体外成骨诱导环境,观察高糖和碱性成纤维细胞生长因子（fibroblastgrowthfactorbFGF）对人骨髓间充质干细胞（humanmesenchymalstemcellshMSCs）成骨分化的影响。方法：hMSC在5．5mmol／L和25mmol／L葡萄糖浓度下培养6天,使用cck一8法测定各组细胞增殖情况;hMSC在两种糖浓度下成骨诱导28天,通过碱性磷酸酶（ALP）活性检测、茜素红染色、钙结节半定量检测,对比各组成骨分化活性;在两种糖浓度成骨诱导液中加入10ng／mlbFGF,使用RT—PCR技术检测各组细胞OCN、OPNmRNA表达差异。结果：高糖较正常糖浓度细胞增殖率下降,ALP活性降低,茜素红染色钙结节量减少,RT—PCR检测结果显示25mmol／L组OCN、OPNmRNA表达量低于5．5mmol／L组,加入bFGF后,25mmol／L组仍低于5．5mmol／L组,与未添加bFGF同葡萄糖组比较表达增加。结论：高糖使hMSC增殖能力下降,在成骨分化的过程中ALP活性降低,成骨相关基因OCN、OPN表达量下降,证明了高糖对hMSC成骨分化具有抑制作用,当加入bFGF后,改善了高糖对hMSC的抑制作用,提示糖尿病条件下高糖的存在是导致hMSC成骨分化能力下降的不利因素,同时初步证明了bFGF参与了成骨分化的过程,从而为在分子水平探讨糖尿病患者种植义齿骨结合形成相关机制奠定初步的基础．．     

不同强度静电磁场对体外培养骨髓间充质干细胞增殖与分化的影响

本实验研究不同强度静电磁场对体外培养大鼠骨髓间充质干细胞增殖与分化作用. 体外分离培养大鼠骨髓间充质干细胞,传代后随机分为6组,分别用强度为0（对照组）、0.9、1.2、1.5、1.8和2.1 mT的静电磁场处理,每d每次处理30 min. 在磁场处理后的9~10 d ,骨髓间充质干细胞开始出现钙化小颗粒. 0.9 mT组抑制骨髓间充质干细胞增殖,1.5到2.1mT组促进骨髓间充质干细胞增殖. 在磁场处理后的12 d和15 d ,1.5和1.8 mT组极显著地增加了碱性磷酸酶(AKP)活性. 采用AKP组织化学染色和钙化结节染色对骨髓间充质干细胞成骨性分化进行鉴定,AKP组织化学染色和钙化结节染色都呈现了极强的阳性结果,尤以1.5 mT和1.8 mT阳性染色面积最大. 在SEMFs处理后的48 h 和96 h ,1.5 mT和1.8 mT组胶原I(collagen-Ⅰ)和骨形态发生蛋白2(bone morphogenetic protein-2, Bmp-2) 基因表达水平显著高于对照组.在SEMFs处理后的12 d, BMP-2蛋白表达量高于对照组. 研究表明,0.9 mT 组抑制骨髓间充质干细胞增殖,1.5 mT到2.1 mT组不同强度静电磁场促进体外培养骨髓间充质干细胞的增殖. 磁场组能促进骨髓间充质干细胞成骨性分化,其中尤以1.5 mT和1.8 mT组促进大鼠骨髓间充质干细胞分化作用效果最为明显.     

尿酸影响人骨髓间充质干细胞成骨分化过程中BMP-2 表达

目的:探讨在人骨髓间充质干细胞(h BMSCs)成骨分化过程中,不同浓度尿酸(UA)对骨形态形成蛋白-2(BMP-2)表达的影响。方法:以全骨髓贴壁培养法分离h BMSCs,将生长状态良好的第3代h BMSCs分为5组,分别为空白对照组(加入完全培养基)和成骨诱导组(加入成骨诱导液及含0 mmol/L、0.2 mmol/L、0.4 mmol/L、0.8 mmol/L尿酸的完全培养基)。连续干预诱导14d后,用倒置显微镜观察细胞形态的变化,通过观察茜素红染色情况及检测碱性磷酸酶(ALP)活性进行成骨情况的检测。RT-PCR技术检测各组细胞BMP-2 mR NA的表达情况。结果:第3代h BMSCs大多为形态单一的长梭形,呈旋涡状生长;干预诱导后的细胞逐渐变成不规则的立方形,局部形成团块状结节,以含尿酸浓度为0.8 mmol/L的成骨诱导培养基最为显著。连续干预14d后,空白对照组茜素红染色为阴性,而各成骨诱导组细胞茜素红染色结果为阳性,提示干预诱导后的细胞为成骨细胞。碱性磷酸酶活性随尿酸浓度的增加和干预时间的延长而增强(P<0.05)。RT-PCR检测结果显示,空白对照组无BMP-2 mR NA的表达。成骨诱导组随培养基中尿酸浓度的增加,BMP-2 mR NA表达逐渐增强,呈浓度依赖性(P<0.05)。结论:尿酸上调h BMSCs向成骨细胞分化过程中BMP-2 mR NA的表达。     

尿酸影响人骨髓间充质干细胞成骨分化过程中BMP-2表达（英文）

目的:探讨在人骨髓间充质干细胞(h BMSCs)成骨分化过程中,不同浓度尿酸(UA)对骨形态形成蛋白-2(BMP-2)表达的影响。方法:以全骨髓贴壁培养法分离h BMSCs,将生长状态良好的第3代h BMSCs分为5组,分别为空白对照组(加入完全培养基)和成骨诱导组(加入成骨诱导液及含0 mmol/L、0.2 mmol/L、0.4 mmol/L、0.8 mmol/L尿酸的完全培养基)。连续干预诱导14d后,用倒置显微镜观察细胞形态的变化,通过观察茜素红染色情况及检测碱性磷酸酶(ALP)活性进行成骨情况的检测。RT-PCR技术检测各组细胞BMP-2 mR NA的表达情况。结果:第3代h BMSCs大多为形态单一的长梭形,呈旋涡状生长;干预诱导后的细胞逐渐变成不规则的立方形,局部形成团块状结节,以含尿酸浓度为0.8 mmol/L的成骨诱导培养基最为显著。连续干预14d后,空白对照组茜素红染色为阴性,而各成骨诱导组细胞茜素红染色结果为阳性,提示干预诱导后的细胞为成骨细胞。碱性磷酸酶活性随尿酸浓度的增加和干预时间的延长而增强(P0.05)。RT-PCR检测结果显示,空白对照组无BMP-2 mR NA的表达。成骨诱导组随培养基中尿酸浓度的增加,BMP-2 mR NA表达逐渐增强,呈浓度依赖性(P0.05)。结论:尿酸上调h BMSCs向成骨细胞分化过程中BMP-2 mR NA的表达。     

Effect of Boron on Osteogenic Differentiation of Human Bone Marrow Stromal Cells

Bone marrow stromal cells (BMSCs) have been well established as an ideal source of cell-based therapy for bone tissue engineering applications. Boron (B) is a notable trace element in humans; so far, the effects of boron on the osteogenic differentiation of BMSCs have not been reported. The aim of this study was to evaluate the effects of boron (0, 1, 10,100, and 1,000?ng/ml) on osteogenic differentiation of human BMSCs. In this study, BMSCs proliferation was analyzed by cell counting kit-8 (CCK8) assay, and cell osteogenic differentiation was evaluated by alkaline phosphatase (ALP) activity assay, Von Kossa staining, and real-time PCR. The results indicated that the proliferation of BMSCs was no different from the control group when added with B at the concentration of 1, 10, and 100?ng/ml respectively (P?>?0.05); in contrast, 1,000?ng/ml B inhibited the proliferation of BMSCs at days?4, 7, and 14 (P?相似文献   

BMP-6-induced osteogenic differentiation of mesenchymal cell lines is not modulated by sex steroids and resveratrol

Bone morphogenetic protein-6 (BMP-6) is a potent inducer of osteogenic differentiation and its expression is stimulated by 17beta-estradiol. The existence of a regulatory loop between sex steroids and BMP-6 is therefore reasonable to hypothesize. Here we determined whether the sex steroids 17beta-estradiol and dihydrotestosterone, and the phytoestrogen resveratrol can modulate BMP-6-induced alkaline phosphatase activity and osteocalcin expression. Mesenchymal cells of murine (osteoblastic MC3T3-E1 cells, preadipogenic ST2 cells, prechondrogenic ATDC5 cell) and human origin (osteosarcoma SaOS and HOS cells, primary bone marrow stromal cells) were cultured in the presence of recombinant BMP-6 under serum-free conditions. BMP-6 dose-, and time-dependently increased alkaline phosphatase activity in murine cell lines, but not in human cells. Osteocalcin expression was also increased upon stimulation with BMP-6. The presence of 17beta-estradiol, dihydrotestosterone, and resveratrol had no effect on BMP-6-induced alkaline phosphatase activity and osteocalcin expression. These data suggest that osteogenic differentiation in response to BMP-6 occurs independent of steroid hormones and resveratrol in mesenchymal cells that express basal receptor levels.     

Simvastatin induces osteoblastic differentiation and inhibits adipocytic differentiation in mouse bone marrow stromal cells

To clarify the mechanism of the stimulatory effect of statins on bone formation, we investigated the effect of simvastatin, a widely used statin, on osteoblastic and adipocytic differentiation in primary cultured mouse bone marrow stromal cells (BMSCs). Simvastatin treatment enhanced the expression level of mRNA for osteocalcin and protein for osteocalcin and osteopontin, and increased alkaline phosphatase activity significantly (p<0.05). After BMSCs were exposed to an adipocyte differentiation agonist, Oil Red O staining, fluorescence activated cell sorting, and decreased expression level of lipoprotein lipase mRNA showed that treatment with simvastatin significantly inhibits adipocytic differentiation compared to controls that did not receive simvastatin (p<0.05). Lastly, we found that simvastatin induces high expression of BMP(2) in BMSCs. These observations suggested that simvastatin acts on BMSCs to enhance osteoblastic differentiation and inhibits adipocytic differentiation; this effect is at least partially mediated by inducing BMP(2) expression in BMSCs.     

Self-assembled extracellular macromolecular matrices and their different osteogenic potential with preosteoblasts and rat bone marrow mesenchymal stromal cells

Extracellular environment is a physical support that is critical to cell adhesion, migration, and differentiation. In this work, cell-derived matrices (CDMs) were obtained by separately culturing fibroblasts, preosteoblasts, and chondrocytes. The cells were grown on a coverslip and subjected to decellularization using detergents and enzymes. The resulting matrices were named fibroblast-derived matrix (FDM), preosteoblast-derived matrix (PDM), and chondrocyte-derived matrix (CHDM). We hypothesize that the unique compositional and structural feature of each CDM provides cells with a distinct microenvironment capable of functioning as a different signaling cue in the regulation of preosteoblast and rat bone marrow mesenchymal stromal cell (BMSC) osteogenic differentiation. SEM images show that each cell type creates its unique surface texture in a fibrillar structure. Three major macromolecules, fibronectin, type I collagen, and laminin, were clearly identified using both immunofluorescence and Western blot, in which FDM exhibited a much stronger signal of each ECM component than that of PDM or CHDM. For early cell morphology, BMSCs on the CDMs were highly elongated in a spindle-like shape. Both preosteoblasts and BMSCs proliferated well on CDMs comparable to the control. Once preosteoblasts were cultured for 2 weeks, their osteogenic activity was significantly different depending on the type of CDM. Using Alizarin red and von Kossa staining, we found that the cells on the FDM were much more osteogenic than the other groups. Furthermore, FDM was the most effective in upregulating the osteogenic markers, such as alkaline phosphatase (ALP), osteopontin, osteocalcin, and type I collagen. In particular, we observed a 2.5-fold increase in ALP activity with FDM compared to that of control and CHDM. In stark contrast, CHDM was very poor in stimulating osteogenic differentiation of preosteoblasts. Interestingly, these results were reproducible with the use of BMSCs, which are much more heterogeneous in cell populations than preosteoblasts. CHDM was still very weak in triggering the osteogenesis of BMSCs, whereas both FDM and PDM were equally competitive. This study demonstrates that a combination of factors (surface texture and composition) shape a unique cellular microenvironment, which serves as a physical cue toward the osteogenic differentiation of preosteoblasts and BMSCs.     

Expression of glutamyl aminopeptidase by osteogenic induction in rat bone marrow stromal cells

Glutamyl aminopeptidase (GluAP, EC 3.4.11.7, ENPEP) is a 130-kDa homodimeric zinc metallopeptidase which specifically cleaves the N-terminal glutamate or aspartate residue of peptidic substrates such as cholecystokinin-8 or angiotensin (Ang) II, in vitro. We used a DNA microarray hybridization (Genechip Rat Expression Array 230A, Affymetrix Inc., Santa Clara, CA, USA) to demonstrate that GluAP was upregulated in osteogenic induced rat bone marrow stromal cells (BMSCs). To compare the expression of GluAP in the osteogenic differentiation and non-osteogenic differentiation of rat BMSCs in vitro, the cells were osteogenic induced in vitro. We also performed an MTT assay, alkaline phosphatase assay, alizarin red staining, and an immunohistochemical analysis to determine the osteogenic differentiation of BMSCs. The expression of GluAP was examined by real-time polymerase chain reaction (PCR). The real-time PCR results showed that GluAP was upregulated in osteogenic differentiated BMSCs in vitro, suggesting that GluAP may be correlated with the osteogenic differentiation of BMSCs.